MDT

96.67

+0.59%↑

A

137.56

-0.2%↓

VEEV

224.65

-0.07%↓

HQY

91.97

-0.76%↓

PHR.US

17

+0.18%↑

MDT

96.67

+0.59%↑

A

137.56

-0.2%↓

VEEV

224.65

-0.07%↓

HQY

91.97

-0.76%↓

PHR.US

17

+0.18%↑

MDT

96.67

+0.59%↑

A

137.56

-0.2%↓

VEEV

224.65

-0.07%↓

HQY

91.97

-0.76%↓

PHR.US

17

+0.18%↑

MDT

96.67

+0.59%↑

A

137.56

-0.2%↓

VEEV

224.65

-0.07%↓

HQY

91.97

-0.76%↓

PHR.US

17

+0.18%↑

MDT

96.67

+0.59%↑

A

137.56

-0.2%↓

VEEV

224.65

-0.07%↓

HQY

91.97

-0.76%↓

PHR.US

17

+0.18%↑

Search

Phibro Animal Health Corp

Cerrado

SectorSanidad

37.27 -0.75

Resumen

Variación precio

24h

Actual

Mínimo

36.79

Máximo

37.67

Métricas clave

By Trading Economics

Ingresos

9.3M

27M

Ventas

-15M

364M

P/B

Media del Sector

22.385

78.892

BPA

0.73

Rentabilidad por dividendo

1.29

Margen de beneficios

7.29

Empleados

2,475

EBITDA

22M

63M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

+24.44% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

1.29%

2.38%

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-225M

1.5B

Apertura anterior

38.02

Cierre anterior

37.27

Noticias sobre sentimiento de mercado

By Acuity

42%

58%

132 / 374 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Strong Bullish Evidence

Phibro Animal Health Corp Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

29 dic 2025, 22:03 UTC

Principales Movimientos del Mercado

Mining Stocks Slip Near the End of Stellar Year

29 dic 2025, 15:57 UTC

Principales Movimientos del Mercado

Praxis Shares Rise on Ulixacaltamide Breakthrough Designation

29 dic 2025, 23:43 UTC

Charlas de Mercado

Nikkei May Decline; Yen in Focus -- Market Talk

29 dic 2025, 23:38 UTC

Adquisiciones, fusiones, absorciones

Manus: Will Continue to Operate From Singapore

29 dic 2025, 23:38 UTC

Adquisiciones, fusiones, absorciones

Manus: Will Continue to Sell, Operate Product Subscription Service Through App, Website

29 dic 2025, 23:37 UTC

Adquisiciones, fusiones, absorciones

Meta Platforms: Will Integrate Manus Service Into Products

29 dic 2025, 23:36 UTC

Adquisiciones, fusiones, absorciones

Meta Platforms: Will Continue to Operate, Sell Manus Service

29 dic 2025, 23:36 UTC

Adquisiciones, fusiones, absorciones

Meta Platforms: Manus's Talent to Join Team to Deliver General-Purpose Agents Across Consumer, Business Products

29 dic 2025, 23:35 UTC

Adquisiciones, fusiones, absorciones

Manus to Join Meta Platforms

29 dic 2025, 21:33 UTC

Adquisiciones, fusiones, absorciones

Origin: Raise Values Kraken at US$8.65 Billion

29 dic 2025, 21:33 UTC

Adquisiciones, fusiones, absorciones

Origin: Octopus Targeting Kraken Separation by Mid 2026

29 dic 2025, 21:31 UTC

Adquisiciones, fusiones, absorciones

BlueScope: Rezoning Will Allow for Range of Commercial, Industrial Development Uses

29 dic 2025, 21:31 UTC

Adquisiciones, fusiones, absorciones

BlueScope Also Says Land Adjacent to Port Kembla Steelworks Rezoned to Special Purpose

29 dic 2025, 21:30 UTC

Adquisiciones, fusiones, absorciones

Origin's Kraken Stake to Remain at 22.7%

29 dic 2025, 21:30 UTC

Adquisiciones, fusiones, absorciones

Origin Will Continue to Hold Its 22.7% Interest in Octopus

29 dic 2025, 21:30 UTC

Adquisiciones, fusiones, absorciones

BlueScope: Guidance Reflects Sustained Strength of Operating Performance in Recent Months

29 dic 2025, 21:30 UTC

Adquisiciones, fusiones, absorciones

Origin: Additional Interest Offsets Dilution From Raise

29 dic 2025, 21:30 UTC

Adquisiciones, fusiones, absorciones

BlueScope Doesn't Expect Material Impact on 1H Guidance Range

29 dic 2025, 21:29 UTC

Adquisiciones, fusiones, absorciones

Origin Waiving Australia Exclusivity to Kraken in Exchange for Additional 1.5% Equity Interest

29 dic 2025, 21:29 UTC

Adquisiciones, fusiones, absorciones

BlueScope Expects to Complete Property Sale for A$76 Million Consideration

29 dic 2025, 21:29 UTC

Adquisiciones, fusiones, absorciones

BlueScope Expects to Complete Property Sale in 2H of FY 2026

29 dic 2025, 21:28 UTC

Adquisiciones, fusiones, absorciones

BlueScope: Selling Residentially Zoned Land in West Dapto to Large Homebuilder

29 dic 2025, 21:28 UTC

Adquisiciones, fusiones, absorciones

Origin: Kraken's Raise Paves Way for Separation From Octopus Energy

29 dic 2025, 21:28 UTC

Adquisiciones, fusiones, absorciones

Origin: Kraken to Raise Total US$1 Billion From New, Existing Investors

29 dic 2025, 21:28 UTC

Adquisiciones, fusiones, absorciones

BlueScope Steel Exchanges Contracts for Sale of 33 Hectares of Land in West Dapto

29 dic 2025, 21:27 UTC

Adquisiciones, fusiones, absorciones

Origin Energy to Invest US$140M in Kraken's Standalone Equity Raise

29 dic 2025, 20:22 UTC

Charlas de Mercado

Oil Rebounds As Russia-Ukraine War Seen Continuing -- Market Talk

29 dic 2025, 20:14 UTC

Charlas de Mercado

U.S. Natural Gas Futures Rise As Front Month Expires -- Market Talk

29 dic 2025, 20:02 UTC

Adquisiciones, fusiones, absorciones

Union Pacific--Norfolk Southern Merger Targets Trucking Market Share -- Barrons.com

29 dic 2025, 17:36 UTC

Charlas de Mercado

U.S. Natural Gas Inventories Swing to Deficit Vs. 5-Year Average -- Market Talk

Comparación entre iguales

Cambio de precio

Phibro Animal Health Corp previsión

Precio Objetivo

By TipRanks

24.44% repunte

Estimación a 12 Meses

Media 47.5 USD  24.44%

Máximo 50 USD

Mínimo 45 USD

De acuerdo con 2 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Phibro Animal Health Corp Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

2 ratings

1

Comprar

1

Mantener

0

Vender

Puntuación técnica

By Trading Central

17 / N/ASoporte y Resistencia

Corto Plazo

Strong Bullish Evidence

Medio plazo

Weak Bearish Evidence

Largo Plazo

Weak Bearish Evidence

Sentimiento

By Acuity

132 / 374 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Coyuntura alcista

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Phibro Animal Health Corp

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine adjuvants for animal's health and performance, food safety, and animal welfare; and engages in development, manufacturing, and marketing of microbial and bioproducts for various applications serving animal health and nutrition, environmental, industrial, and agricultural customers. In addition, the company develops, manufactures, and markets conventionally licensed and autogenous vaccine products, as well as adjuvants for animal vaccine manufacturers. Further, it provides formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds to fortify the daily feed requirements of their livestock's diets and maintain optimal balance of trace elements in animals. Additionally, the company offers specialty ingredients for personal care, industrial chemical, and chemical catalyst industries. It sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle producers, as well as through commercial animal feed manufacturers, wholesalers, and distributors. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was founded in 1946 and is headquartered in Teaneck, New Jersey.